European Archives - Page 591 of 1120 - European Medical Journal

EMJ Podcast: Keeping Calm in a Crisis

Meryvn Singer, Professor of Intensive Care Medicine, UCL, discusses the role of intensive care in the pandemic and beyond, consider what physicians have learnt over the past 12 months, and reveal why innovation has peaked during COVID-19.

How Much Sugar Do You Take?

DANGERS of consuming sugar have been further investigated in a new study, which indicated that a person’s metabolism may be adversely affected with even…

Formerly Rare Gallbladder or Bile Duct Cancer on the Rise

https://codex.wordpress.org/Excerpt

Screening for Lung Cancer with Low-Dose Spiral CT: An Updated Review

IN 2020, lung cancer was the second most common cancer and the leading cause of death from cancer among both males and females in the USA. Screening…

Correlation Between COVID-19 Lung Severity and Neurologic Symptoms

CORONAVIRUS disease (COVID-19) has been linked to the development of neurological symptoms and complications in patients who become ill with the…

EMJ Cardiology 9 [Supplement 2] 2021 feature image

Novel Insights into Cardiac Biomarkers in Atrial Fibrillation, Heart Failure, and Coronary Heart Disease | Advancing Understanding and Clinical Application of Cardiac Biomarkers

Oral anticoagulation is currently underused in AF management, with one-third of cases remaining silent and asymptomatic. The STROKESTOP…

EMJ Cardiology 9 [Supplement 2] 2021 feature image

EMJ Cardiology 9 [Supplement 2] 2021

The proCardio event, a global Cardiac Biomarker Forum, was held virtually as a series of three webinars from 12th to 14th October 2020…

Can Machine Learning Accurately Identify Malignant Blood Disorders?

YELODYSPLASTIC syndrome (MDS) is a disorder that disrupts the maturation and differentiation of haematopoietic stem cells in the bone marrow.

Infographic: Brain–Computer Interfaces

A brain–computer interface (BCI) measures, analyses, and translates the activity of the central nervous system (CNS) into artificial…

Talking to Rob Jekielek

Rob Jekielek, Managing Director, The Harris Poll, discusses the evolving public perceptions of the pharma industry.